Enfortumab Vedotin Shows Promise for Urothelial Carcinoma ...Middle East

The antibody-drug conjugate enfortumab vedotin is superior to chemotherapy in patients with previously treated advanced urothelial carcinoma, primary results of the EV-301 trial show. Medscape Medical News

Hence then, the article about enfortumab vedotin shows promise for urothelial carcinoma was published today ( Monday 01/03/2021 - 09:16 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Enfortumab Vedotin Shows Promise for Urothelial Carcinoma )

Also on site :

• Natural gas line rupture stops traffic on 5 Freeway in Castaic
• No. 20 Virginia notches first 11-win season by beating 25th-ranked Missouri in the Gator Bowl
• SK Telecom Unveils A.X K1, Korea's First 500B-Scale Hyperscale AI Model